Raina, SapnaAnand, Bhupinder KaurSingh, Marwaha Manvinder PalParihaar, JKS2019-11-162019-11-162018-04Raina Sapna, Anand Bhupinder Kaur, Singh Marwaha Manvinder Pal, Parihaar JKS. Use of Anti Angiogenic Drug in the Treatment for Age Related Macular Degeneration. International Archives of BioMedical and Clinical Research. 2018 Apr-Jun; 4(2): 158-1612454-98942454-9886http://imsear.searo.who.int/handle/123456789/184160Background: Age-related macular degeneration (AMD) is the leading cause of irreversible blindness. Currently 2.5-3 million people worldwide are blind due to AMD. Objective:- This study were to  use of anti-angiogenic drug in the treatment for age related macular degeneration. Methods: A cross sectional study was carried out among patients attending Eye OPD of a tertiary care eye center. Results: 25 patients were included in this study . Among the 25 patients 15 were male & 10 were female. Mean visual acuity (VA) in this study improved from 5/60 to 6/36 during follow up. This was statistically significant (P <0.0001). Conclusion: The results of this study suggest that IVB (1.25 mg) is well tolerated and associated with stabilization or improvement in visual acuity, decreased central macular thickness (CMT) by ocular coherence tomography (OCT), and reduction in angiographic leakage associated with neovascular AMD.Angiogenic DrugMacular DegenerationEye OpdIvbBevacizumabJournal ArticleIndia1Assistant Professor; Classified Specialist Ophthalmology, Air Force Central Medical Establishment (AFCME), New Delhi, IndiaProfessor, Department of Community Medicine, SGT Medical University, Gurugram, Haryana, India.Classified Specialist Aerospace Medicine, Air Force Central Medical Establishment (AFCME), New Delhi, India.Senior Consultant, Department of Ophthalmology, Center of Sight, New Delhi, India